MedTrace Logo

Evaluation of the Signals Electrophysiological Measured by Intelligent Textiles

NCT03805243 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2021-11-11

No results posted yet for this study

Summary

BioSerenity suggests developing innovative solutions, from intelligent clothes which can be used in a hospital environment or at home. These textiles allow, in particular, to measure the biophysiological signals while letting to the participant the freedom pursue its daily activities.

BioSerenity has already developed two wearable wireless and portable medical devices: cardioskin with textile ECG electrods , and the Neuronaute with textile EEG, EMG electrods.

The aim of the study is to test these sensors to optimize their signal to integrate them in future Bioserenity devices like a somnonaute to help diagnosis of sleep disorders, like uronaute to help diagnosis of urination disorders, like toconaute to help monitoring of pregnancy. Others CE-marked sensors developed by others manufacturers will be tested to choose those that will be integrated in the Bioserenity devices.

Conditions

  • Healthy

Interventions

DEVICE

test of sensors for somnonaute device

test of sensors

DEVICE

test of sensors for uronaute device

test of sensors

DEVICE

test of sensors for toconaute device

test of sensors

DEVICE

test of sensors for neuronaute device

test of sensors

DEVICE

test of sensors for cardioskin device

test of sensors

Sponsors & Collaborators

  • BioSerenity

    lead INDUSTRY

Principal Investigators

  • quang TRAN · BioSerenity

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-29
Primary Completion
2020-12-21
Completion
2020-12-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03805243 on ClinicalTrials.gov